UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Sable Offshore Corp
SOC
$918M
| $6.72M | ﹤0.01% |
293,236
+245,266
| +511% | +$5.37M |
|
3502
CALL
Sherwin-Williams
SHW
$89.8B
| $6.7M | ﹤0.01% |
19,700
+7,500
| +61% | +$2.8M |
|
|
3503
PUT
Sherwin-Williams
SHW
$89.8B
| $6.7M | ﹤0.01% |
19,700
+7,500
| +61% | +$2.8M |
|
|
LAC
3504
Lithium Americas
LAC
$1.13B
| $6.69M | ﹤0.01% |
2,253,024
+2,189,692
| +3,457% | +$7.59M |
|
3505
PUT
Infosys
INFY
$50.6B
| $6.69M | ﹤0.01% |
305,200
-25,000
| -8% | -$559K |
|
3506
Insperity
NSP
$2.03B
| $6.68M | ﹤0.01% |
86,196
+71,971
| +506% | +$5.83M |
|
3507
Installed Building Products
IBP
$6.57B
| $6.67M | ﹤0.01% |
38,082
-987
| -3% | -$215K |
|
3508
Golub Capital BDC
GBDC
$3.43B
| $6.67M | ﹤0.01% |
440,135
+151,597
| +53% | +$2.31M |
|
3509
PUT
Yum China
YUMC
$16.3B
| $6.66M | ﹤0.01% |
138,200
+110,000
| +390% | +$5.22M |
|
3510
Brookfield Infrastructure Partners
BIP
$17.8B
| $6.65M | ﹤0.01% |
209,037
+3,912
| +2% | +$133K |
|
3511
COPT Defense Properties
CDP
$4.23B
| $6.64M | ﹤0.01% |
214,683
+111,296
| +108% | +$3.54M |
|
|
CALY
3512
Callaway Golf Company
CALY
$3.16B
| $6.64M | ﹤0.01% |
844,846
+623,090
| +281% | +$5.66M |
|
3513
iShares Russell Top 200 ETF
IWL
$2.28B
| $6.63M | ﹤0.01% |
45,838
+2
| +0% | +$289 |
|
3514
Alarm.com
ALRM
$2.84B
| $6.62M | ﹤0.01% |
108,961
+61,045
| +127% | +$3.64M |
|
3515
Structure Therapeutics
GPCR
$3.75B
| $6.62M | ﹤0.01% |
244,063
+204,983
| +525% | +$7.27M |
|
3516
FormFactor
FORM
$9.15B
| $6.61M | ﹤0.01% |
150,151
+64,198
| +75% | +$2.76M |
|
3517
VanEck Vietnam ETF
VNM
$505M
| $6.59M | ﹤0.01% |
574,312
+395,948
| +222% | +$4.72M |
|
3518
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
| $6.59M | ﹤0.01% |
84,295
-5,216
| -6% | -$406K |
|
3519
John Hancock Multifactor Developed International ETF
JHMD
$991M
| $6.59M | ﹤0.01% |
205,439
-9,550
| -4% | -$321K |
|
|
CPZ
3520
Calamos Long/Short Equity & Dynamic Income Trust
CPZ
$267M
| $6.57M | ﹤0.01% |
442,750
+46,607
| +12% | +$723K |
|
3521
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$108M
| $6.55M | ﹤0.01% |
263,117
-208
| -0.1% | -$5.38K |
|
3522
Myriad Genetics
MYGN
$311M
| $6.55M | ﹤0.01% |
477,572
+273,613
| +134% | +$5.05M |
|
3523
Core Laboratories
CLB
$518M
| $6.53M | ﹤0.01% |
377,092
+349,888
| +1,286% | +$6.75M |
|
3524
CALL
Cigna
CI
$74.8B
| $6.52M | ﹤0.01% |
23,600
-7,500
| -24% | -$2.39M |
|
3525
Option Care Health
OPCH
$3.58B
| $6.5M | ﹤0.01% |
280,285
+49,059
| +21% | +$1.24M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.